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Pancreatic  β-cells are major cells responsible for glucose metabolism in the body. Hyperglycemia is
known to be a primary factor in the induction of diabetes mellitus. Glutamate is also an excitatory
neurotransmitter in diverse organs. Oxidative stress also plays a pivotal role in the development of
diabetes mellitus. However, the effect of hyperglycemia in glutamate uptake in the pancreas is not clear.
Furthermore, the relationship between high glucose-induced glutamate uptake and oxidative stress has
not been investigated. Therefore, this study was conducted to investigate the effect of high glucose on
glutamate uptake in pancreatic β-cells. In the present study, 25 mM glucose stimulated the glutamate
uptake in HIT-15 cells of hamster pancreatic β-cells. The treatment of 25 mM glucose and 1 mM
glutamate also decreased the cell viability in HIT-15 cells. In addition, the treatment of 25 mM glucose
induced an increase of lipid peroxide formation. High glucose-induced increase of LPO formation was
prevented by the treatment of antioxidants such as N-acetyl-L-cysteine and quercetin. Furthermore, high
glucose-induced stimulation of glutamate uptake and decrease of cell viability were also blocked by the
treatment of N-acetyl-L-cysteine and quercetin. In conclusion, high glucose stimulated glutamate uptake
via oxidative stress in pancreatic β-cells.
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The pancreas is an important organ for regulating glucose
metabolism in the body [1]. Glucose transported into β-cells
induced by the increase of plasma glucose levels leads to
insulin exocytosis, which manipulates the glucose levels [2].
Hyperglycemia has been known to be a primary factor in
triggering diabetes in digestive organs [3]. Glutamate is the
most important excitatory amino acid in the nervous system
[4]. Recently, it has been reported that glutamate regulates
the diverse function of digestive organs [5]. Several lines of
evidence suggest that glutamate induces metabolic syndrome
such as obesity and diabetes-like hyperglycemia [6,7]. Di
Cairano et al [8] also reported that the glutamate transporter
is expressed in pancreatic β-cells and is responsible for the
protection of glutamate-induced β-cell death. These reports
suggest that there may be an interaction between hyper-
glycemia and glutamate in the pancreas, since the pancreas
plays a pivotal role in the regulation of glucose metabolism.
However, the regulation of glutamate uptake by hyperglycemia
in the pancreas has not been elucidated.
Diverse signaling molecules are involved in the onset of
diabetes mellitus [9]. Among them, oxidative stress, which
is manifested as increased levels of reactive oxygen species
(ROS), has been generally reported to be associated with
the development of diabetes [10,11]. Several lines of evidence
have suggested that N-acetyl-L-cysteine (NAC) and quercetin
protects the diabetes-related oxidative stress in the pancreas
[12,13]. These reports suggest the possibility that oxidative
stress is involved in the high glucose-induced regulation of
glutamate uptake. Thus, this study was conducted to investigate
the effect of high glucose on glutamate uptake and its
relationship with oxidative stress in pancreatic β-cells.
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Materials and Methods
Materials
RPMI 1640medium, fetal bovine serum (FBS), penicillin,
and streptomycin were obtained from Hyclone (Logan, UT,
USA). HIT-T15 cells were obtained from the American-Type
Culture Collection (ATCC, Manassas, VA, USA). D-Glucose
was obtained from Sigma (St. Louis, MO, USA). [
3H]-L-
glutamate
 was purchased from Dupont/NEN (Boston, MA,
USA). All reagents were of the highest purity commercially
available.
Cell cultures
We used HIT-T15 cells as a model to study pancreatic
β-cells. HIT-T15 cells were cultured in RPMI 1640 medium
containing 10% FBS, 100 U/mL penicillin, and 100 µg/mL
streptomycin at 37
oC in 5% CO2. Cells (1×10
4 cells/well)
were seeded in a 96-well plate and pre-incubated with the
same media in a serum-free condition for 24 h.
Cell viability assay
Cell viability was evaluated by the colorimetric MTT assay,
using the CellTiter 96
® AQueous One solution according to
the manufacturer's instructions. Briey, cells (1×10
6 cells/well)
were seeded in a 96-well plate with RPMI 1640 medium
containing 10% FBS, 100 U/mL penicillin, and 100 µg/mL
streptomycin at 37
oC in 5% CO2. Then, the cells were pre-
incubated with the same media in a serum-free condition
(without FBS) for 24 h and were treated with 25 mM glucose




3H]-aspartate uptake experiments were carried
out using a modification of the method described by Wu
et al [14]. To study the D-[2,3-
3H]-aspartate uptake, the culture
medium was removed by aspiration, and the cells were gently
washed twice with an uptake buffer (140 mM NaCl, 2 mM
KCl, 1 mM KH2PO4, 10 mM MgCl2, 1 mM CaCl2, 5 mM
glucose, 5 mM L-alanine, 5 µM indomethacin, and 10 mM
HEPES/Tris, pH7.4). After washing, the cells were incubated
in an uptake buffer containing 1 µCi/mL D-[2,3-
3H]-aspartate
at 37
oC for 1 h in 5% CO2 in a humidified cell culture incubator.
At the end of the incubation period, the cells were washed
three times with an ice-cold uptake buffer and then dissolved
in 1 mL 0.1% sodium dodecyl sulfate (SDS). The level of
D-[2,3-
3H]-aspartate uptake incorporated intracellularly was
determined by removing 900 µL of each sample and
measuring the radioactivity in a LS 6500 liquid scintillation
counter (Beckman Instruments, Fullerton, CA, USA). The
remainder of each sample was used to determine the protein
level by the method of Bradford [15]. The radioactivity counts
in each sample were then normalized with respect to the
protein and corrected for zero-time uptake per mg of protein.
All the uptake measurements were carried out in triplicate.
Measurement of lipid peroxides
The levels of lipid peroxides (LPO) in the monolayer cells
were determined by measuring the malondealdehyde content
according to the method of Ohkawa et al [16]. ARPE-19
cells were exposed to 25 mM glucose for 24 h. After exposure
terminated, the cells were harvested and sonicated. 100 µL
of sonicated cells was mixed with 8% sodium dodecyl sulfate
(100 µL), 0.8% 2-thiobarbituric acid (TBA, 200 µL) and 20%
acetic acid (200 µL). The mixture was heated to 95 for 60
min. After reaction time, this mixture was cooled in ice-cold
water. To extract the nonspecific red pigment, n-butanol-
pyridine mixture (15:1 v/v, 1 mL) was added, and the mixture
was shaken vigorously, and was then centrifuged at 4,000
rpm for 10 min. The upper organic layer was measured by
spectrofluorometry at an emission wavelength of 553 nm with
an excitation wavelength of 515 nm. 1,1,3,3-Tetraethoxy-
propane was used as a standard and the values of LPO for
samples were expressed as nmol/mg protein.
Statistical analysis
The results were expressed as the mean±SE. All the
experiments were analyzed by analysis of variance (ANOVA).
In some experiments, a comparison of the treatment means
was made with the control using the Bonnferroni-Dunn test.
A P value <0.05 was considered significant.
Results
Dose-dependent effect of high glucose on glutamate
uptake
To examine the dose-dependent effect of high glucose on
glutamate uptake, the HIT-15 cells were treated with different
dosages of glucose (10, 25,or 50 mM), 25 mM mannitol, or
25 mM  L-glucose. As shown in Figure 1A, 25 mM and 50
mM glucose, but not 10 mM glucose, significantly stimulated
D-[2,3-
3H]-aspartate uptake. However, treatment with 25 mM
mannitol or L-glucose did not further change D-[2,3-
3H]-
aspartate uptake, suggesting that the uptake was glucose
specific (Figure 1B). In addition, we examined the time
dependent effect of glucose. Thus, HIT-15 cells were exposed
to 25 mM glucose for 0-480 min. As shown in Figure 1B,
25 mM glucose significantly stimulated D-[2,3-
3H]-aspartate
uptake for over 30 min, with a maximum effect at 480 minGlutamate uptake by high glucose in pancreatic β-cells 329
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after high glucose treatment. Thus, 25 mM glucose for 8 h
was used in subsequent experiments. Furthermore, we
examined high glucose and glutamate induced cell death
in HIT-15 cells. Figure 2 demonstrates that high glucose (25
mM and 50 mM glucose), but not 25 mM mannitol, induced
the decrease of cell viability. Similarly, the treatment of 1 mM
glutamate also decreased the cell viability.
The involvement of oxidative stress in high glucose-
induced stimulation of glutamate uptake and cell
viability
The relationship between oxidative stress and high glucose-
induced stimulation in glutamate uptake was examined. NAC
(1 mM) and quercetin (100 µM) antioxidants were used to
treat the HIT-15 cells prior to incubation with 25 mM glucose.
As shown in Figure 3A, 25 mM glucose induced the increase
of LPO formation. NAC and quercetin both blocked high
glucose-induced LPO formation. Figure 3B also demonstrated
Fig. 2. Dose response of 25 mM glucose on cell proliferation.
Different dosages of glucose (25 or 50 mM glucose), 25 mM
mannitol, or 1 mM L-glutamate were administered to HIT-T15
cells for 24 h and cell proliferation was determined using MTT
assay. Values are mean±SE of three independent experiments
performed in triplicate. *P<0.05 vs control (Control: 5 mM
glucose).
Fig. 3. Effect of N-acetyl-L-cysteine (NAC) and quercetin on
high glucose-induced lipid peroxide formation (A) and D-[2,3-
3H]-aspartate uptake (B). NAC (1 mM) and quercetin (100 µM)
were used to treat the HIT-T15 cells for 30 min prior to the
treatment of 25 mM glucose for 8 h. Then, lipid peroxides and
D-[2,3-
3H]-aspartate uptake were conducted. *P<0.05 vs
control, **P<0.05 vs 25 mM glucose alone.
Fig. 1. Time and dose response of 25 mM glucose on D-[2,3-
3H]-aspartate uptake. (A) Dose dependent effect of glucose and
the effect of osmotic load on D-[2,3-
3H]-aspartate uptake.
Different dosages of glucose (10, 25 or 50 mM glucose), 25
mM mannitol, or 25 mM L-glucose were administered to HIT-
T15 cells. (B) HIT-T15 cells were treated with 25 mM glucose at
different time intervals (0-480 min). Then, D-[2,3-
3H]-aspartate
uptake was determined. Values are mean±SE of three
independent experiments performed in triplicate. *P<0.05 vs
control (Con: 5 mM glucose).330 Ho Jae Han, Soo Hyun Park
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that NAC and quercetin blocked the high glucose-induced
stimulation of glutamate uptake. NAC and quercetin prevented
the high glucose-induced decrease of cell viability (Figure 4).
These results suggest that oxidative stress is involved in the
high glucose-induced stimulation of glutamate uptake and
the decrease of cell viability.
Discussion
This study firstly demonstrated that high glucose stimulated
the glutamate uptake in hamster pancreatic β-cells. Until now,
the regulation of glutamate was restricted to the nervous system.
However, several lines of evidence have suggested that the
metabolism of glutamate is important in the function of non-
neural tissues [17-19]. In the present study, high glucose
stimulated the glutamate uptake in pancreatic β-cells. These
stimulatory effects are D-glucose-specific and are unlikely due
to an osmotic effect since the responses were not mimicked
by mannitol or L-glucose. To our knowledge, this is the first
report in which hyperglycemia stimulated the glutamate uptake
in pancreatic β-cells. In pancreatic β-cells, glial glutamate
transporter 1 and the vesicle glutamate transporter are
expressed [20,21]. In the present study, we did not examine
the isoforms of the glutamate transporters. This remains to
be studied. Our result also demonstrated that high glucose
and glutamate induced the decrease of cell viability. Our
result is inconsistent with several reports. Gong et al [22]
reported that hyperglycemia induces apoptosis of pancreatic
islet endothelial cells. Venieratos et al [23] also showed that
high glucose induces apoptosis in mouse pancreatic β-cells.
Based upon our result and these reports, we provide the
evidence that high glucose-induced stimulation of glutamate
is associated with the apoptosis of pancreatic β-cells.
Changes in signal transduction pathways may potentially
play an important role in the overall effect of glucose on
glutamate uptake. ROS accumulation induces oxidative stress.
Increased ROS occurs due to an imbalance of processes that
produce ROS and processes that reduce ROS (antioxidant
systems) in the pancreas [24]. In the present study, high glucose
increased the LPO formation and antioxidants such as NAC
and quercetin prevented the high glucose-induced stimulation
of glutamate uptake and the decrease of cell viability. Zhang
et al [25] also reported a similar result in which high glucose
increased oxidative stress and these phenomena lead to β-
cell apoptosis. However, they did not examine the role of
glutamate. In agreement with our results, Penugonda et al
[26] demonstrated that NAC derivative protects the glutamate-
induced cytotoxicity in the neuronal cell line. High glucose-
induced stimulation of glutamate uptake and stimulation of
LPO formation have been reported in many various cells
and tissues [27,28]. Nevertheless, there is still no direct
evidence demonstrating the relationship between glutamate
uptake and LPO formation in pancreatic β-cells. Here, we
provide further evidence that high glucose-induced induced
increase of LPO formation leads to the stimulation of glutamate
uptake, which may be associated with the apoptosis of
pancreatic β-cells. There is a possibility that the high glucose-
induced stimulation of glutamate uptake triggers the increase
of oxidative stress, since L glutamate enhances cell toxicity
via the increase of oxidative stress [29]. It is speculated that
mechanisms other than oxidative stress could have a role
in the glucose-induced stimulation of glutamate uptake. This
needs to be elucidated in a further study. In summary, in
the HIT-T15 cells, the pancreatic β-cells, oxidative stress
appears to mediate the high glucose-induced stimulation of
glutamate uptake. In addition, oxidative stress is also involved
in mediating the high glucose-induced decrease of cell viability.
Therefore, our findings may provide new insights into the
pathophysiological mechanisms of glutamate uptake in
diabetes mellitus. In conclusion, high glucose induced the
stimulation of glutamate uptake and decrease of cell viability
via oxidative stress in the pancreatic β-cells.
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